- Abivax aims to set cancer concerns with ulcerative colitis drug to restLate on Monday, Abivax released new trial data on its ulcerative colitis candidate, showing that cancer cases in a Phase 3 trial were within the expected range for these patients. The company says…Endpoints · 25d ago↗ source
- Health AI caution crosses into confidenceHow people in health tech feel about AI in healthcare has changed drastically from just a year ago. Each year, health tech venture firm Venrock partners Bob Kocher, Bryan Roberts and Siobhan Nola…Endpoints · 25d ago↗ source
- FDA's acting director of cell and gene therapies to leave positionVijay Kumar is leaving his role as acting director of CBER's Office of Therapeutic Products and will soon consider options both inside and outside the FDA, he told Endpoints News on Tuesday. Kuma…